Two biotypes of Streptococcus bovis can be identified by laboratory testing and can be distinguished from the phenotypically similar organism Streptococcus salivarius. We assessed the clinical relevance of careful identification of these organisms in 68 patients with streptococcal bacteremia caused by these similar species. S. bovis was more likely to be clinically significant when isolated from blood (89%) than was S. salivarius (23%). There was a striking association between S. bovis I bacteremia and underlying endocarditis (94%) compared with that of S. bovis II bacteremia (18%). Bacteremia with S. bovis I was also highly correlated with an underlying colonic neoplasm (71% of patients overall, 100% of those with thorough colonic examinations) compared with bacteremia due to S. bovis Il or S. salivarius (17% overall, 25% of patients with thorough colonic examinations). We conclude that careful identification of streptococcal bacteremic isolates as S. bovis biotype I provides clinically important information and should be more widely applied.
The association between bacteremia caused by Streptococcus bovis and gastrointestinal disease, particularly colonic malignancy, is well documented (8-10, 12, 14) . However, most previous studies have not reported the physiological characteristics of S. bovis strains in detail, and thus the distribution of isolates among the different biotypes of S. bovis is unknown. We have previously observed similarities in the physiological reactions of S. bovis and the viridans group species Streptococcus salivareus which could result in the erroneous identification of S. salivareus as S. bovis (16) and could confound the relationship between bacteremia caused by S. bovis and specific disease states. In a study of phenotypic characteristics and genetic relationships of S. bovis and S. salivarius, Coykendall and Gustafson (3) noted that in spite of phenotypic similarities, S. salivarius and S. bovis strains were genetically distinct at the species level. Previous studies of physiological characteristics of S. bovis isolates have identified two biotypes. S. bovis, also called S. bovis I, was differentiated from S. bovis variant, also referred to as S. bovis II, on the basis of mannitol fermentation and starch hydrolysis reactions and the ability to produce polysaccharide from sucrose (5, 13 (15) reported a case of endocarditis due to S. salivarius associated with colonic adenocarcinoma, and Hoecker and co-workers (7) reported six cases of sepsis due to S. salivarius in children with underlying malignant diseases. Our data suggest a possible hepatobiliary origin for many clinically significant infections with S. salivarius and S. bovis subbiotype II/1, an anatomical correlation not previously recognized for either of these organisms.
We conclude that accurate differentiation between isolates of S. bovis and S. salivarius and biotyping of isolates of S. bovis provide clinically useful information. Problems in identifying these physiologically similar organisms with presumptive tests have been discussed previously (16) , but our experiences and those of others (6) have demonstrated the utility of the API Rapid Strep system for identification of these organisms; other commercially available systems may also be of use for this purpose (4) . No clear distinction in the clinical significance of the subbiotypes of S. bovis Il could be observed from our data. Our findings suggest that identification of S. bovis to the level of biotype I or Il and distinction between these organisms and S. salivarius should be more widely applied.
